Quantumzyme Announces Removal of OTC Markets Caveat Emptor Designation
The removal of the designation follows the Company's full cooperation with OTC Markets and the implementation of enhanced disclosure practices, including updated financial reports, identity verification, and corporate transparency measures. Quantumzyme also retained experienced securities counsel to support the process and ensure full regulatory compliance.
'We are pleased to announce that the Caveat Emptor warning has been lifted,' stated Naveen Kulkarni, CEO of Quantumzyme. 'Transparency, compliance, and market integrity are top priorities for us, and we are committed to maintaining the highest standards as we execute our business plan and build shareholder value.'
With the Caveat Emptor designation lifted, we are excited to return our full focus to executing our business strategy and driving long-term value for shareholders. We appreciate the patience and support of our investors throughout this process, and we hope the investing public recognizes that our proactive cooperation, transparency, and compliance efforts have led to a successful resolution. Quantumzyme remains committed to maintaining open communication and the highest standards of corporate governance moving forward.
Quantumzyme reiterates that it had no involvement in the unauthorized promotional messages that were circulated in March 2025. The Company continues to condemn such promotional activity and has cooperated fully with all related inquiries.
For the most current information and updates, please visit our website at www.quantumzymecorp.com and the Company's profile at www.otcmarkets.com/stock/QTZM.
About Quantumzyme Corp.
Quantumzyme Corp. is a pioneering biotransformation company revolutionizing chemical processes through sustainable, enzyme-based solutions. Specializing in green chemistry, it harnesses quantum mechanics, molecular modeling, AI-driven simulations, and computational enzyme engineering to design high-performance biocatalysts that enhance efficiency, reduce waste, and minimize environmental impact. By integrating computational modeling with wet-lab validation, Quantumzyme delivers scalable, cost-effective biocatalysis solutions that improve industrial sustainability. Offering end-to-end enzyme development services - from discovery and engineering to process optimization and scale-up - Quantumzyme empowers its partners to adopt greener, more efficient production methods. Committed to sustainability and innovation, the company envisions a future where biotechnology drives global solutions for climate change, pollution, and resource efficiency, making eco-friendly biocatalysis the industry standard.
Disclaimer
The information contained in this press release is provided by Quantumzyme Corp. ('Quantumzyme') for general informational purposes only. This release may include forward-looking statements that reflect Quantumzyme's current expectations, estimates, projections, and assumptions about future events, business performance, market conditions, or technological developments. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied in such statements. Forward-looking statements are based on management's beliefs and assumptions as of the date of this press release and are subject to change without notice.
Quantumzyme makes no representations or warranties, express or implied, regarding the accuracy, completeness, or reliability of the information contained herein. The company undertakes no obligation to publicly update or revise any forward-looking statements as a result of new information, future developments, or changes in expectations, except as required by applicable law. Past performance should not be taken as an indicator of future results, and readers should not place undue reliance on any projections or expectations presented in this release.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor does it provide financial, investment, or legal advice. Any references to market trends, scientific advancements, or industry insights are provided for contextual purposes only and should not be interpreted as endorsements, guarantees, or definitive predictions of future developments. Readers and investors are encouraged to conduct their own due diligence and seek independent professional advice before making any investment or business decisions related to Quantumzyme or its affiliates.
Contact:
Naveen Kulkarni
Chief Executive Officer
Quantumzyme Corp.
15656 Bernardo Center Drive, Suite 801
San Diego, CA 92127
Phone: +1 (858) 203-0312
Email: [email protected]
Website: www.quantumzymecorp.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
OTC Markets Group Reports Second Quarter 2025 Financial Results Delivering Revenue, Operating Income, and Earnings Growth
Second Quarter 2025 Highlights: Gross revenues of $30.5 million for the quarter, up 11% versus the prior year period Operating income of $8.8 million for the quarter, up 8% versus the prior year period Operating profit margin of 29.9%, versus 30.4% for the prior year period Net income of $7.3 million, up 8% versus the prior year period, and quarterly diluted GAAP EPS of $0.60, up 7% Total cash returned to shareholders during the quarter of $2.2 million, in the form of dividends Announcing third quarter 2025 dividend of $0.18 per share 556 OTCQX® and 1,073 OTCQB® companies at quarter end 18 graduates to a national securities exchange during the quarter 113 subscribers to OTC Link ECN as of June 30, 2025, versus 114 as of June 30, 2024 137 unique OTC Link subscribers as of June 30, 2025, versus 140 as of June 30, 2024 Approximately 63,000 average daily trades during the quarter versus approximately 35,000 during the prior year period Launched OTCID™ with 1,035 OTCID companies as of July 1, 2025 NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced its financial results for the second quarter of 2025. 'During the second quarter, our team completed the work for the successful launch of our OTCID Basic Market on July 1, 2025,' said R. Cromwell Coulson, President and Chief Executive Officer. 'This evolution of our markets expands the opportunities available for public companies to support informed and efficient trading of their securities. Engaged public companies, who are committed to ongoing transparency, are critical to improving market quality. The future of investor relations is digital and having consistent and compliant information on investor screens and in broker machines will drive visibility and valuations.' 'Our business delivered top and bottom line growth in the second quarter,' said Antonia Georgieva, Chief Financial Officer. 'We saw increased revenues across our business lines, with OTC Link benefitting from continued elevated trading volumes, and Market Data Licensing benefitting from price increases and subscriber growth. Our Corporate Services business saw continued improvement in sales. We remain committed to continuously enhancing our offerings, driving growth in users and usage of our products, and delivering long-term value to our shareholders.' Second Quarter 2025 compared to Second Quarter 2024 Financial Highlights Three Months Ended June 30, (in thousands, except shares and per share data) 2025 2024 % change $ change OTC Link $ 6,447 $ 5,408 19 % 1,039 Market data licensing 12,316 10,782 14 % 1,534 Corporate services 11,742 11,372 3 % 370 Gross Revenues 30,505 27,562 11 % 2,943 Net revenues 29,507 26,771 10 % 2,736 Revenues less transaction-based expenses 27,215 25,222 8 % 1,993 Operating expenses 18,384 17,082 8 % 1,302 Income from operations 8,831 8,140 8 % 691 Operating profit margin 29.9% 30.4% Income before provision for income taxes 9,047 8,324 9 % 723 Net income $ 7,300 $ 6,733 8 % 567 Diluted earnings per share $ 0.60 $ 0.56 7 % Adjusted diluted earnings per share $ 0.92 $ 0.85 8 % Weighted-average shares outstanding, diluted 11,830,514 11,838,453 - Gross revenues of $30.5 million, up 11% over the prior year quarter. Revenues less transaction-based expenses up 8%. OTC Link revenues up 19%. Transaction-based revenues from OTC Link ECN and OTC Link NQB up 40% due to a higher volume of shares traded on those platforms. Contributing to the overall increase in OTC Link revenues were also an increase in OTC Link ATS messages revenue due to a higher number of messages, an increase in certain connectivity revenue due to growth in the number of connection licenses, and higher QAP service revenue related to the higher volume of trading activity. Market Data Licensing revenues up 14%. Redistributor-based revenues increased 20%, with professional user revenues increasing 28%, partially offset by a decline in non-professional user revenues of 31% quarter over quarter. Revenues from direct sold licenses increased 16% primarily due to price increases for certain licenses and growth in subscribers. Revenues from data and compliance solutions remained essentially unchanged, with lower revenue from EDGAR Online offset by increases in revenues from data services and our Blue Sky data product. Corporate Services revenues up 3%. Revenues from our OTCQX and OTCQB markets increased 2% and 4%, respectively, reflecting price increases effective from the beginning of the year, which offset a lower number of companies on the OTCQX and OTCQB markets. Revenues from our Disclosure & News Service® ('DNS') product increased 13% due to price increases and a higher number of companies subscribing to DNS in anticipation of the July 1, 2025 launch of OTCID. The previously announced retirement of OTCIQ Basic partially offset these increases. Operating expenses increased 8%. The increase was primarily driven by a 6% increase in compensation and benefits, 21% increase in professional and consulting fees, and 12% increase in IT infrastructure and information services. Operating income and net income each increased 8%, to $8.8 million and $7.3 million, respectively. Adjusted EBITDA, which excludes non-cash stock-based compensation expense, increased 8% to $11.1 million, or $0.92 per adjusted diluted share. Dividend Declaration – Quarterly Cash Dividend OTC Markets Group announced today that its Board of Directors authorized and approved a quarterly cash dividend of $0.18 per share of Class A Common Stock. The quarterly cash dividend is payable on September 18, 2025, to stockholders of record on September 4, 2025. The ex-dividend date is September 4, 2025. Stock Buyback Program The Company is authorized to purchase shares from time to time on the open market, from employees and consultants, and through block trades, in compliance with applicable law. The Company did not repurchase any shares during the second quarter of 2025. On March 11, 2025, the Board of Directors refreshed the Company's stock repurchase program, giving the Company authorization to repurchase up to 300,000 shares of the Company's Class A Common Stock. Non-GAAP Financial Measures In addition to disclosing results prepared in accordance with GAAP, the Company also discloses certain non-GAAP results of operations, including adjusted EBITDA and adjusted diluted earnings per share that either exclude or include amounts that are described in the reconciliation table of GAAP to non-GAAP information provided at the end of this release. Non-GAAP financial measures do not replace and are not superior to the presentation of GAAP financial results but are provided to improve overall understanding of the Company's current financial performance. Management believes that this non-GAAP information is useful to both management and investors regarding certain additional financial and business trends related to the operating results. Management uses this non-GAAP information, along with GAAP information, in evaluating its historical operating performance. Second Quarter 2025 Conference Call The Company will host a conference call and webcast on Thursday, August 7, 2025, at 8:30 a.m. Eastern Time, during which management will discuss the financial results in further detail. The call and webcast may be accessed as follows: Webcast:The conference webcast and management presentation can be accessed at the following link (replay available until August 6, 2026): Live Call:Participants intending to ask a question during the live call and Q&A session should also register in advance at: Upon registration, participants will receive a dial-in number along with a unique PIN number that can be used to access the live call. Live call participants may also select a 'Call Me' option. The Quarterly Report, earnings release, transcript of the earnings call, and management presentation will also be available in the Investor Relations section of the corporate website at About OTC Markets Group Inc. OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our public markets: OTCQX® Best Market, OTCQB® Venture Market, OTCID Basic Market, and Pink Limited™ Market. Our OTC Link® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets. OTC Link ATS, OTC Link ECN, OTC Link NQB, and MOON ATS® are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC. To learn more about how we create better informed and more efficient markets, visit Investor Contact: Antonia GeorgievaChief Financial OfficerPhone: (212) 220-2215Email: ir@ Media Contact: OTC Markets Group (212) 896-4428Email: media@ OTC MARKETS GROUP INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (in thousands, except share and per share information) Three Months Ended June 30, 2025 2024 OTC Link $ 6,447 $ 5,408 Market data licensing 12,316 10,782 Corporate services 11,742 11,372 Gross revenues 30,505 27,562 Redistribution fees and rebates (998 ) (791 ) Net revenues 29,507 26,771 Transaction-based expenses (2,292 ) (1,549 ) Revenues less transaction-based expenses 27,215 25,222 Operating expenses Compensation and benefits 11,573 10,934 IT Infrastructure and information services 2,858 2,545 Professional and consulting fees 1,842 1,521 Marketing and advertising 438 362 Occupancy costs 668 576 Depreciation and amortization 656 682 General, administrative and other 349 462 Total operating expenses 18,384 17,082 Income from operations 8,831 8,140 Other income Other income 216 184 Income before provision for income taxes 9,047 8,324 Provision for income taxes 1,747 1,591 Net Income $ 7,300 $ 6,733 Earnings per share Basic $ 0.61 $ 0.56 Diluted $ 0.60 $ 0.56 Basic weighted average shares outstanding 11,769,861 11,723,459 Diluted weighted average shares outstanding 11,830,514 11,838,453 Non-GAAP Reconciliation Three Months Ended June 30, 2025 2024 Net Income $ 7,300 $ 6,733 Excluding: Interest expense (income) (215 ) (187 ) Provision for income taxes 1,747 1,591 Depreciation and amortization 656 682 Stock-based compensation expense 1,627 1,496 Adjusted EBITDA $ 11,115 $ 10,315 Adjusted diluted earnings per share $ 0.92 $ 0.85 Note: We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of our GAAP financial results, but are provided to improve overall understanding of the Company's current financial MARKETS GROUP INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share information) June 30, December 31, 2025 2024 Assets Current assets Cash and cash equivalents $ 36,796 $ 34,522 Short-term investments 4,860 4,513 Accounts receivable, net of allowance for credit losses of $343 and $326 8,515 8,097 Prepaid income taxes 750 244 Prepaid expenses and other current assets 2,808 2,237 Total current assets 53,729 49,613 Property and equipment, net 6,229 7,096 Operating lease right-of-use assets 10,239 10,951 Deferred tax assets, net 11,031 10,120 Goodwill 3,984 3,984 Intangible assets, net 6,538 6,829 Long-term restricted cash 1,606 1,606 Other assets 460 543 Total Assets $ 93,816 $ 90,742 Liabilities and stockholders' equity Current liabilities Accounts payable $ 1,102 $ 1,175 Income taxes payable 3 54 Accrued expenses and other current liabilities 10,269 13,425 Deferred revenue 26,930 29,084 Total current liabilities 38,304 43,738 Income tax reserve 1,007 927 Operating lease liabilities 9,564 10,360 Total Liabilities 48,875 55,025 Commitments and contingencies Stockholders' equity Common stock - par value $0.01 per share Class A - 17,000,000 authorized, 12,909,365 issued, 12,017,933 outstanding at June 30, 2025; 12,815,075 issued, 11,979,165 outstanding at December 31, 2024 129 128 Additional paid-in capital 38,270 35,127 Retained earnings 32,214 23,200 Treasury stock - 891,432 shares at June 30, 2025 and 835,910 shares at December 31, 2024 (25,672 ) (22,738 ) Total Stockholders' Equity 44,941 35,717 Total Liabilities and Stockholders' Equity 93,816 90,742
Yahoo
5 hours ago
- Yahoo
Bakkt Expands Global Bitcoin Play With 30% Stake in Japan's Marusho Hotta
Amid a sea of new crypto treasury companies popping up, Bakkt and BitBridge are in the news today, after they both provided updates on their bitcoin treasury strategies. Bakkt (BKKT), the technology firm that went all-in on crypto, has signed a deal to acquire nearly one-third of Japanese trading company Marusho Hotta (8105), in a move that could signal a broader international bitcoin (BTC) strategy for the U.S.-based digital asset platform, the company said in a press release Wednesday. Under the agreement with RIZAP Group Inc., Bakkt will acquire roughly 30% of the Tokyo-listed company, positioning itself as Marusho Hotta's largest shareholder. Pending shareholder approval, Marusho Hotta will be renamed aligning its brand with its new bitcoin-centric direction, the company said. Bakkt has also secured the domain as part of the deal. In a strategic leadership shift, Phillip Lord, President of Bakkt International, will take over as CEO of Marusho Hotta. Meanwhile, bitcoin treasury firm BitBridge Capital Strategies has completed its merger with Green Mountain Merger Inc., the company said in a press release yesterday. The company will start trading under the ticker symbol BTTL on the over-the-counter (OTC) markets by the end of the third quarter, with plans to uplist to NASDAQ thereafter.
Business Wire
7 hours ago
- Business Wire
Shareholder Alert: The Ademi Firm Investigates Whether PharmChem, Inc. is Obtaining a Fair Price for its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating PharmChem (OTC: PCHM) for possible breaches of fiduciary duty and other violations of law in its transaction with Alcohol Monitoring Systems. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of PharmChem will receive $3.75 per share in cash. PharmChem insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for PharmChem by imposing a significant penalty if PharmChem accepts a competing bid. We are investigating the conduct of the PharmChem board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
